Jacobs Levy Equity Management
PBYI icon

Jacobs Levy Equity Management’s Puma Biotechnology PBYI Stock Holding History

Jacobs Levy Equity Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-756,675
Closed -$2.3M – 1063
2021
Q4 		$2.3M Buy
756,675
+313,594
+71% +$1.36M 0.02% 592
2021
Q3 		$3.11M Buy
443,081
+262,137
+145% +$1.96M 0.02% 531
2021
Q2 		$1.66M Buy
180,944
+6,251
+4% +$63.3K 0.01% 636
2021
Q1 		$1.7M Buy
174,693
+71,165
+69% +$795K 0.01% 636
2020
Q4 		$1.06M Sell
103,528
-1,015
-1% -$10.3K 0.01% 706
2020
Q3 		$1.05M Sell
104,543
-4,146
-4% -$42.2K 0.01% 652
2020
Q2 		$1.13M Buy
108,689
+25,244
+30% +$261K 0.01% 643
2020
Q1 		$704K Sell
83,445
-42,730
-34% -$415K 0.01% 697
2019
Q4 		$1.1M Buy
126,175
+21,355
+20% +$177K 0.01% 674
2019
Q3 		$1.13M Buy
104,820
+66,460
+173% +$718K 0.01% 601
2019
Q2 		$488K Sell
38,360
-5,220
-12% -$120K 0.01% 743
2019
Q1 		$1.69M Buy
43,580
+26,040
+148% +$795K 0.02% 547
2018
Q4 		$357K Buy
17,540
+12,330
+237% +$370K 0.01% 785
2018
Q3 		$239K Buy
+5,210
New +$251K ﹤0.01% 903
2018
Q1 		– Sell
-7,297
Closed -$721K – 1041
2017
Q4 		$721K Buy
+7,297
New +$817K 0.01% 682

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Jacobs Levy Equity Management's PBYI Position: Q1 2022 in Review

Jacobs Levy Equity Management sold out of Puma Biotechnology (PBYI) in Q1 2022, closing a stake of 756,675 shares — an estimated $2.3M sold.

Jacobs Levy Equity Management first reported a position in PBYI in Q4 2017 and held it in 15 quarters. The position peaked at $3.11M in Q3 2021. 104 funds tracked by Wall St. Rank hold PBYI as of Q1 2022.

  • Jacobs Levy Equity Management reported no remaining Puma Biotechnology position as of Q1 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 756,675 Puma Biotechnology shares in Q1 2022, an estimated $2.3M.
  • Jacobs Levy Equity Management first reported a position in Puma Biotechnology in Q4 2017 and held it in 15 quarters.
  • Jacobs Levy Equity Management's Puma Biotechnology position peaked at $3.11M in Q3 2021.
  • 104 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2022, filed 16 May 2022.